Triazine derivatives and their therapeutical applications

Details Triazine derivatives and their therapeutical applications Triazine derivatives and their therapeutical applications

2007-12-14

2010-12-28

Balasubramanian, Venkataraman (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Four or more ring nitrogens in the bicyclo ring system

C544S198000, C544S208000, C544S209000, C514S245000

Reexamination Certificate

active

07858782

ABSTRACT:
The invention provides for Triazine derivatives and their use to modulate protein kinase activity in a variety of conditions and diseases.

REFERENCES:
patent: 5916596 (1999-06-01), Desai et al.
patent: 6288228 (2001-09-01), Henkin et al.
patent: 6340683 (2002-01-01), Marzabadi et al.
patent: 6440965 (2002-08-01), Kelley et al.
patent: 6498165 (2002-12-01), Armstrong et al.
patent: 6506405 (2003-01-01), Desai et al.
patent: 6537579 (2003-03-01), Desai et al.
patent: 6596746 (2003-07-01), Das et al.
patent: 2004/0116388 (2004-06-01), Armistead et al.
patent: 2005/0227983 (2005-10-01), Timmer et al.
patent: 2005/0250945 (2005-11-01), Li et al.
patent: 2006/0004067 (2006-01-01), Chen et al.
patent: WO 99/32106 (1999-07-01), None
patent: WO 01/25220 (2001-04-01), None
patent: WO 01/81311 (2001-11-01), None
patent: WO 01/94341 (2001-12-01), None
patent: WO 02/08205 (2002-01-01), None
patent: WO 02/16352 (2002-02-01), None
patent: WO 02/083653 (2002-10-01), None
patent: WO 03/014111 (2003-02-01), None
patent: WO 03/018021 (2003-03-01), None
patent: WO 03/024448 (2003-03-01), None
patent: WO 03/026666 (2003-04-01), None
patent: WO 2004/058776 (2004-07-01), None
patent: WO 2005/003103 (2005-01-01), None
patent: WO 2005/007646 (2005-01-01), None
patent: WO 2005/007648 (2005-01-01), None
patent: WO 2005/011703 (2005-02-01), None
patent: WO 2005/096784 (2005-10-01), None
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Mass, R. D., Int. J. Radiation Oncology Bio. Phys.vol. 58(3): 932-940, 2004.
Fabbro et al. Pharmacology & therapeutics 93, 79-98, 2002.
Bhavsar et al., Asian Journal of Chemistry (1999), 11(1), 65-70; CA 130:15359, 1999.
Desai et al., Journal of the Indian Chemical Society (1994), 71(3), 151-3; CA 122:81316, 1995.
Freiberg et al., Journal fuer Praktische Chemie (Leipzig) (1987), 329(2), 259-70; CA 108:75351,1988.
Patel et al., Journal of the Institution of Chemists (India) (1984), 56(2), 99-100; CA 101:130667, 1984.
Rembarz et al., Naturwissenschaftliche Reihe (1982), 31(9), 11-15; CA 100:6463, 1984.
Abram et al.,Exp. Cell. Res., 254, 1-13 (2000).
Anderson et al.,Adv. Immunol., 56, 151-178 (1994).
Appleby et al.,Cell, 70, 751-763 (Sep. 4, 1992).
Arvanitis et al.,J. Med. Chem., 42, 805-818 (1999).
Baindur et al.,J. Med. Chem., 48, 1717-1720 (2005).
Baliani et al.,J. Med. Chem., 48, 5570-5579 (2005).
Biscardi et al.,Adv. Cancer Res., 76, 61-119 (1999).
Bolen, Joseph B.,Oncogene, 8, 2025-2031 (1993).
Bolen et al.,Annu. Rev. Immunol., 15, 371-404 (1997).
Boschelli et al.,Drugs of the Future, 25 (7), 717-736 (2000).
Boschelli et al.,J. Med. Chem., 47, 1599-1601 (2004).
Boyce et al.,J. Clin. Invest., 90, 1622-1627 (Oct. 1992).
Brown et al.,Biochim. Biophys. Acta, 1287, 121-149 (1996).
Brugge et al.,Nature, 269, 346-348 (Sep. 1977).
Cartwright et al.,Proc. Natl. Acad. Sci. USA, 87, 558-562 (Jan. 1990).
Collett et al.,Proc. Natl. Acad. Sci. USA, 75 (4), 2021-2024 (Apr. 1978).
Egan et al.,Oncogene, 18, 1227-1237 (1999).
Fanning et al.,Cancer Res., 52, 1457-1462 (Mar. 15, 1992).
Frame, Margaret C.,Biochim. Biphys. Acta, 1602, 114-130 (2002).
Garcia-Bustos et al.,EMBO J., 13 (10), 2352-2361 (1994).
Goldman et al.,J. Clin. Invest., 102 (2), 421-429 (Jul. 1998).
Hamaguchi et al.,Oncogene, 10, 1037-1043 (1995).
Hanks et al.,FASEB J., 9, 576-596 (May 1995).
Hiwasa et al.,FEBS Lett., 444, 173-176 (1999).
Hunter et al.,Proc. Natl. Acad. Sci. USA, 77 (3), 1311-1315 (Mar. 1980).
Irby et al.,Nat. Genet., 21, 187-190 (Feb. 1999).
Jankowski et al.,Gut, 33, 1033-1038 (1992).
Kane et al.,Curr. Opn. Immunol., 12, 242-249 (2000).
Karni et al.,Oncogene, 18, 4654-4662 (1999).
Klein et al.,Mol. Cell. Biol., 17 (11), 6427-6436 (Nov. 1997).
Klein et al.,EMBO J., 18 (18), 5019-5027 (1999).
Knighton et al.,Science, 253, 407-414 (Jul. 26, 1991).
Kumar et al.,J. Biol. Chem., 273 (40), 25654-25658 (Oct. 2, 1998).
Kumar et al.,J. Med. Chem., 49, 3395-3401 (2006).
Leftheris et al.,J. Med. Chem., 47, 6283-6291 (2004).
Lombardo et al.,J. Med. Chem., 47, 6658-6661 (2004).
Lowell et al.,J. Leukocyte Biol., 65, 313-320 (Mar. 1999).
Lutz et al.,Biochem. Biophys. Res. Comm., 243, 503-508 (1998).
Lynch et al.,Leukemia, 7 (9), 1416-1422 (Sep. 1993).
Mao et al.,Oncogene, 15, 3083-3090 (1997).
Mazurenko et al.,Eur. J. Cancer, 28 (2/3), 372-377 (1992).
Menicagli et al.,J. Med. Chem., 47, 4649-4652 (2004).
Moasser et al.,Cancer Res., 59, 6145-6152 (Dec. 15, 1999).
Molina et al.,Nature, 357, 161-164 (May 14, 1992).
Muthuswamy et al.,Oncogene, 11, 1801-1810 (1995).
Owens et al.,Mol. Biol. Cell, 11, 51-64 (Jan. 2000).
Parang et al.,Expert. Opn. Ther. Patents, 15 (9), 1183-1207 (2005).
Parang et al.,Curr. Opn. Drug Disc. Dev., 7 (5), 617-629 (2004).
Paul et al.,Nat. Med., 7 (2), 222-227 (Feb. 2001).
Pawson Tony,Nature, 373, 573-580 (Feb. 16, 1995).
Rodriguez et al.,J. Med. Chem., 47, 600-611 (2004).
Sakamoto et al.,Jpn J. Cancer Res., 92, 941-946 (Sep. 2001).
Soriano et al.,Cell, 64, 693-702 (Feb. 22, 1991).
Staley et al.,Cell Growth&Diff., 8, 269-274 (Mar. 1997).
Sun et al.,Biochemistry, 44, 14455-14462 (2005).
Susa et al.,TiPS, 21, 489-495 (Dec. 2000).
Takayanagi et al.,J. Clin. Invest., 104 (2), 137-146 (Jul. 1999).
Talamonti et al.,J. Clin. Invest., 91, 53-60 (Jan. 1993).
Tatosyan et al.,Biochemistry(Moscow), 65 (1), 49-58 (2000).
Taylor et al.,Mol. Cell. Biol., 15 (8), 4149-4157 (Aug. 1995).
Thomas et al.,Ann. Rev. Cell Dev. Biol., 13, 513-609 (1997).
Turner et al.,Nature, 402 (Supp), B24-B30 (Nov. 25, 1999).
Vicentini et al.,J. Immunol., 168, 6446-6454 (2002).
Warmuth et al.,Curr. Pharm. Design, 9, 2043-2059 (2003).
Whitesell et al.,Curr. Cancer Drug Targets, 3, 349-358 (2003).
Wiener et al.,Clin. Cancer Res., 5, 2164-2170 (Aug. 1999).
Whitten et al.,J. Med. Chem., 39, 4354-4357 (1996).
Ye et al.,Biochemistry, 43, 15775-15784 (2004).
Yeatman, Timothy J.,Nat. Rev., 4, 470-480 (Jun. 2004).
Partial International Search Report PCT/US2007/087576 (Apr. 24, 2008).
Rininsland et al.,BMC Biotechnology, 5:16, pgs. 1-6, (2005).
Promega Technical Bulletin, “CellTiter-Blue® Cell Viability Assay” (Revised Jun. 2009).

Affiliated with

Also associated with

Rating

Triazine derivatives and their therapeutical applications does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazine derivatives and their therapeutical applications, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazine derivatives and their therapeutical applications will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4183332